GlassScriptPhysician profile
Farnaz D Carter
NPI 1275797938
$711.66
in general payments reported to CMS, 2019-2025
14 companies · $206 in 2025
The $206 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.88 · 2022: $147 · 2023: $94.31 · 2024: $234 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.20 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $144.34 | 2021-2025 | |
| Astellas Pharma US INC | $108.33 | 2023-2024 | Veozah |
| Biogen, INC. | $98.33 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $60.94 | 2025 | Slynd |
| Coopersurgical, INC. | $44.29 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Pfizer INC. | $38.47 | 2024 | |
| Hologic Sales and Service, LLC | $35.40 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Myovant Sciences INC. | $35.08 | 2022 | |
| Mylan Pharmaceuticals INC. | $34.43 | 2022 | |
| Optumhealth Care Solutions, LLC | $33.15 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Mayne Pharma Commercial LLC | $26.32 | 2023 | |
| Aspira Women'S Health INC | $23.30 | 2022 | |
| Boston Scientific Corporation | $16.32 | 2021 | |
| Novo Nordisk INC | $12.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farnaz Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.